Effect of C-344T polymorphism of aldosterone synthase gene on variability of antihypertensive therapy with angiotensin II receptor blockers: open randomized controlled clinical trial
The effectiveness of the antihypertensive therapy may be associated with genetic factors that affect not only the degree of a blood pressure elevation but also predetermine an interindividual variability in response to the antihypertensive treatment.The aim of the work was to study pharmacodynamic i...
Saved in:
| Main Authors: | E. V. Rebrova, E. V. Shikh, N. B. Lazareva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute
2024-11-01
|
| Series: | Фармация и фармакология (Пятигорск) |
| Subjects: | |
| Online Access: | https://www.pharmpharm.ru/jour/article/view/1543 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
С(-344)Т polymorphism of aldosterone synthase gene, risk of metabolic syndrome, and atrial fibrillation risk for inhabitants of the Northwest regions of Russia
by: I. Ma, et al.
Published: (2016-06-01) -
Adrenal aldosterone synthase (CYP11B2) histopathology and its association with disease-induced sudden death: a cross-sectional studyResearch in context
by: Antero Ylänen, et al.
Published: (2025-04-01) -
Pathology and gene mutations of aldosterone-producing lesions
by: Koshiro Nishimoto, et al.
Published: (2023-12-01) -
Prediction of pharmacokinetic/pharmacodynamic properties of aldosterone synthase inhibitors at drug discovery stage using an artificial intelligence-physiologically based pharmacokinetic model
by: Mengjun Zhang, et al.
Published: (2025-04-01) -
Gene polymorphism of aldosterone synthetase (CYP11B2) variants and main cardiovascular risk factors
by: L. Ye. Lobach, et al.
Published: (2016-12-01)